A Safety and Efficacy Study to Evaluate Rosacea

Inclusion Criteria: * Healthy male and/or female subjects between the ages of 18 and 65 year with rosacea, 10 to 30 papules and pustules (at least 5 lesions within the treatment area on each facial side), and \< 2 nodules * Presence of moderate to severe persistent erythema * Total body weight \>45 kg Exclusion Criteria: * Presence of any skin condition on the face that would interfere with the diagnosis or assessment of rosacea * Extremely dark skin type that would confound the digital analysis of erythema (eg, Fitzpatrick Skin Type 5 or 6) * Excessive facial hair (eg, beards, sideburns, moustaches, etc.), birthmarks, or tattoos that would interfere with diagnosis or assessment of rosacea * Use of tobacco- or nicotine-containing products in excess of the equivalent of 5 cigarettes per day. * Pregnant or nursing females; females of childbearing potential who are unwilling or unable to use an acceptable method of non-hormonal contraception as outlined in this protocol from at least 14 days prior to start of treatment. * Hypersensitivity or allergy to axitinib or any other component of the study treatment * Use within 6 months prior to baseline and during the study of oral retinoids (eg, Accutane®) or therapeutic vitamin A supplements of greater than 10,000 units/day (multivitamins are allowed). * Use within 6 weeks prior to baseline and during the study of vasodilators or α-adrenergic receptor-blocking agents. * Use within 1 month prior to baseline and during the study of 1…